Table 3 Distribution of fimbria and toxins among samples with ≥ 60% haemolytic E. coli-like colonies before and after neomycin treatment
Before treatment | After treatment | |||
|---|---|---|---|---|
Control (n = 75) | Single high-dose (n = 67) | Control (n = 25) | Single high-dose (n = 51) | |
F18 + STb + LT | 97% (n = 73) | 97% (n = 65) | 84% (n = 21) | 75% (n = 38) |
F4 + STb + LT | 3% (n = 2) | 3% (n = 2) | 0% | 6% (n = 3) |
F18 + LT | 0% | 0% | 8% (n = 2) | 10% (n = 5) |
F18a | 0% | 0% | 8% (n = 2) | 6% (n = 3) |
E. colib | 0% | 0% | 0% | 4% (n = 2) |